baber/WOPTO huggingface dataset:
Patent NZ-262484-A (NZ)
Title: An agent for controlling the interaction of a cell with its environment by controlling the transport of intergal membrane proteins (imp)
Inventor: NORTH JOHN ROBERT
IPC: A61K47/48
Filed: 1994-03-18
Abstract: This invention describes a novel agent for the targeted control of a mammalian cell activity, in particular the agent is used to control the interaction of particular cell types with their external environment. The agent has applications as a pharmaceutical for the treatment of a variety of disorders. An agent according to the invention comprises three Domains B, T and E linked together in the following manner: Domain B-Domain T-Domain E where Domain B is the Binding Domain which binds the agent to a Binding Site on the cell which undergoes endocytosis to produce an endosome, Domain T is the Translation Domain which translocates the agent (with or without the Binding Site) from within the endosome across the endosomal membrane into the cytosol of the cell, Domain E is the Effector Domain which inhibits the ability of the Recyclable Membrane Vesicles to transport the Integral Membrane Proteins to the surface of the cell.
Patent NZ-265523-A (NZ)
Title: Medical device: non-metallic member with paramagnetic ionic particles enhances viewing by magnetic imaging
Inventor: YOUNG STUART W
IPC: A61M25/00
Filed: 1994-04-12
Abstract: Catheters and other medical devices include a non-metallic member having paramagnetic ionic particles fixedly incorporated therethrough in order to provide enhanced detectability when viewed by magnetic imaging regardless of the orientation of the non-metallic member in the magnetic field. Catheters are usually formed from polymeric tubing, and the paramagnetic ionic particles are usually formed from paramagnetic ions incorporated with water or other proton-donating fluid into carrier particles, such as zeolites, molecular sieves, clays, synthetic ion exchange resins, and microcapsules. Catheters and other medical devices include a non-metallic member having small iron and/or superparamagnetic particles fixedly incorporated therethrough or thereover in order to provide enhanced detectability when viewed by magnetic imaging. Catheters are usually formed from polymeric tubing, and the iron and/or superparamagnetic particles at or near the surface of the catheter interact with the water protons of the surrounding patient's body to provide image enhancement regardless of the orientation of the polymeric or other non-metallic material in the magnetic field.
Patent NZ-299131-A (NZ)
Title: Use of thrombin blood fraction in keratinocyte cell culture growth and activation of platelets
Inventor: CEDERHOLM-WILLIAMS STEWART ANT
IPC: A61K35/14
Filed: 1993-06-24
Abstract: A method for the cell culture growth of keratinocytes from skin includes the step of adding thrombin to the culture medium, wherein the thrombin is derived from the same individual or animal from which the skin keratinocytes are derived. Compositions containing materials released from platelets may be prepared using thrombin to activate the release of the materials, wherein the thrombin is derived from the same individual or animal as the platelets. The thrombin blood fraction in each method above comprises a thrombin concentration of from 1 NIH unit/ml to 2000 NIH units/ml, and a specific activity of thrombin of from about 1 NIH unit/mg of blood protein to 200 NIH units/mg of blood protein.  The thrombin blood fraction contains less than about 50% activity of antithrombin III in normal plasma per unit volume, and may be used in medicaments for the treatment of blood loss.
Patent NZ-310990-A (NZ)
Title: Pharmaceutical powder cartridge, with an integrated metering slide, and inhaler therefor
Inventor: NARODYLO ANDRE
IPC: A61K9/14
Filed: 1996-06-03
Abstract: A pharmaceutical powder cartridge 100 comprises an integrated metering device 107 which comprises at least one metering cavity 124 for holding a predetermined quantity of a pharmaceutical powder.  Device 107 further comprises a metering slide 123 which can be moved at least out of a filling position into an emptying position approximately transversely with respect to the flow direction of the pharmaceutical powder into the metering slide.  The slide is arranged below a reservoir space 101 for storing the powder when the cartridge is oriented in a way allowing the powder to flow from the reservoir space into the metering cavity of the slide by gravity force.
Patent NZ-321886-A (NZ)
Title: Neuronal stimulation using electrically conducting polymers
Inventor: SHASTRI VENKATRAM
IPC: C12N5/0793
Filed: 1996-10-31
Abstract: ethods and support systems are provided for modifying the regeneration, differentiation, or function of cells. In one embodiment, electrically conducting biocompatible polymers may be used alone or in combination with a polymeric support for in vitro nerve cell regeneration, or in vivo to aid in healing nervous tissue defects. The conductive polymers may be implanted adjacent to or seeded with nerve cells. Voltage or current is applied to the polymer in a range that reduces the desired effect on the cells while not damaging the cells. The methods and systems can be used in a variety of applications to enhance in vivo or in vitro growth or regeneration of nervous tissue.
Patent NZ-332282-A (NZ)
Title: Method for making wort using a enzyme (such as alpha-L-arabinofuranosidase) containing composition having improved filterability and/or increased yield
Inventor: LAROYE MARIE-PAULE
IPC: C12C7/04
Filed: 1997-05-02
Abstract: A process for preparing wort is claimed comprising: (a) preparing mash from malted or unmalted cereals, or a mixture of malted and unmalted cereals, in the presence of a mixture of enzyme activities and (b) filtering the mash so obtained to obtain the wort; wherein the mixture of enzyme activities is selected from a mixture comprising at least b-glucanase activity and a-L-arabinofuranose releasing activity or a mixture comprising at least b-glucanase activity, endo-xylanase activity and a-arabinofuranose releasing activity.
Patent NZ-332658-A (NZ)
Title: Halo-substituted bis-indolylmaleimide derivatives and pharmaceutical compositions
Inventor: JIROUSEK MICHAEL R
IPC: C07D498/22
Filed: 1997-04-30
Abstract: The bis-indolylmaleimide derivative has the formula I wherein: each R' is independently H, halo, OH, alkyl, alkoxy, NR3R4 or NHCO-alkyl; V is O, NH or N-alkyl; W and T are independently alkylene optionally substituted by halo or alkyl; J is -X-C(Y)(Q)- or when T and W are both methylene J is a group of formula II; n and m are independently 1 or 2; X is O, S or a bond between the carbon atom bridged by X; Y is halo, alkyl or H; Q is -C(Z)(R2)-M and R3, R4, Z, M and R2 are as defined in the specification provided that at least one of Y, Q, T or W is halo or a halo substituted group or T and W are both methylene. A pharmaceutical composition thereof useful for treating a disease or condition associated with abnormal protein kinase C activity.
Patent NZ-500149-A (NZ)
Title: Pharmaceutical compositions containing tizoxanide and/or nitazoxinade
Inventor: ROSSIGNOL JEAN-FRANCOIS
IPC: A61P31/04
Filed: 1998-05-06
Abstract: An oral pharmaceutical composition contains at least one active agent selected from nitazoxanide of formula (II) and/or desacetyl-nitazoxanide of formula (I) wherein the active agent has a particle size smaller than 200 mm and greater than 5mm.  The composition is useful for treating opportunistic infections in patients with compromised or suppressed immune systems and for infections of trematodes.
Patent NZ-502011-A (NZ)
Title: Concentration measuring apparatus for measuring a concentration of a specific component in a solution comprising a biosensor system and test strip
Inventor: KAWANAKA SHOJI
IPC: C12Q1/00
Filed: 1998-07-15
Abstract: A concentration measuring apparatus, such as a densitometer, is used for measuring the concentration of a specific component in a solution such as blood. The concentration apparatus comprises a biosensor, a test strip and a method for forming a terminal of a test piece.  An identifying electrode (104) is provided in addition to an anode (102) and a cathode (103) in order to recognize the type of the attached test piece on the measuring instrument (101) side.  A suitable test piece is attached to the instrument which then measures the component in a liquid sample by the electrical connection between the identifying electrode and the terminal of the attached test piece.  Further, a measuring instrument senses a variation for working curve information selection in order to select the working curve information corresponding to the production lot of the attached test piece to compensate the error for the concentration of the component.
Patent NZ-503455-A (NZ)
Title: Electric invoicing and payment system
Inventor: NEELY R ALAN
IPC: G06Q20/40
Filed: 1998-08-19
Abstract: A system for automated electronic invoicing and payment system for providing remote customer review of automated billing from an invoicer. The system includes invoice presentment electronics having a control system and first communication electronics (101). The system also includes at least one remote authorization terminal having a customer interface, the terminal having second communication electronics (110) adapted to operatively communicate with the first communication electronics (101). The control system of the invoice presentment electronics is adapted to provide billing data, regarding a customer invoice preauthorised for automated billing, to the first communication electronics (101) for transmission to the second communication electronics (110). The customer interface of the remote authorization terminal is adapted to present the billing data to a customer and to receive a response relating to the billing data from the customer, the response indicating one of acceptance of the billing data or modification thereto.
Patent NZ-504868-A (NZ)
Title: Patch or hydrogel delivery of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8,-tetrahydronaphthalene-2-ol
Inventor: DA SILVA-JARDINE PAUL ANDREW
IPC: A61K31/439
Filed: 2000-05-31
Abstract: Estrogen agonist-antagonists such as a 5-substituted-6-cyclic-5,6,7,8-tetrahydronaphthalene-ol compounds (pictured) are used to treat conditions such as breast cancer, osteoporosis, obesity, cardiovascular disease, hypercholesterolemia, endometriosis and prostate disease. A transdermal patch delivery system provides administration of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8,-tetrahydronaphthalene-2-ol in daily amounts of 10-500 µg.
Patent NZ-509630-A (NZ)
Title: lightweight spinning reel with large diameter spool and light overall weight for versatility for a variety of fishing line sizes
Inventor: KEMP FRED M
IPC: A01K89/01
Filed: 1999-07-06
Abstract: A light weight, fixed spool spinning fishing reel allowing versatility in line sizes, longer casts, and less line twist. The fishing reel includes a spool (3) with a generally cylindrical channel (4) extending between the opposite faces (5, 6). The outer face (5) has a diameter of greater than two inches. The fishing reel, including the spool (3), has an overall weight of less than nine and one half ounces.
Patent NZ-511714-A (NZ)
Title: Method of producing ribbed board and product thereof
Inventor: LUETGERT KARINE
IPC: B27N3/08
Filed: 1999-11-12
Abstract: A method of producing a ribbed board product (8) from a mat comprising a material selected from a group consisting of wood-based materials, agricultural fibres, and synthetic fibres including adhesive and formed by compressing and curing a mat of the material under heat and pressure between a die. The die has a ribbed configuration with at least two outer zones (11) and at least two angled zones (12).   The method further includes closing the die to form a die gap, wherein the die gap of at least two of the outer zones (11) is less than the die gap of at least two of the angled zones (12).  The mat is consolidating under pressure and heat to form the ribbed board product.
Patent NZ-511982-A (NZ)
Title: Article transfer apparatus comprising a support pillar, arm and connector
Inventor: MAHONEY DONALD SIMSON
IPC: B65G61/00
Filed: 2001-05-28
Abstract: A transfer apparatus (10) for articles (19) comprising, a support (11) and an arm (12) connected to the support (11) and movable between a first and second position vertically displaced relative to one another.  The arm (12) is rotatable about the support 11) in a vertical plane from a first side of the support to a second side of the support (11).  The arm (12) comprises a connector (13) having a releasable attachment for engaging an article (19) and a rotation device (14) to rotate the connector (13).
Patent NZ-516854-A (NZ)
Title: Reinforced abrasive wheels
Inventor: ALBRECHT JEAN-MARIE
IPC: B24D5/16
Filed: 2000-07-24
Abstract: In a depressed-center abrasive wheel assembly (58) a reinforcement layer (14) of polygonal shape is located between a front face (20) of the abrasive wheel (10) and a front flange (50). The reinforcement layer (14) is dimensioned to entirely cover the depressed center portion (32) of the wheel (10). An example of polygonal reinforcement layer (14) has a hexagonal shape and is made of fiberglass cloth. A polygonal shape reinforcement layer (14) can also be employed between the front flange and the front face in an abrasive flat wheel assembly that employs a wheel without internal reinforcement.
Patent NZ-518010-A (NZ)
Title: Electrochemiluminescence assay method for detecting helicase activity in a sample
Inventor: ZANG LITAO
IPC: C12Q1/68
Filed: 2000-10-05
Abstract: An electrochemiluminescent assay method for detecting helicase activity in a sample whereby the sample is combined with a first nucleic acid molecule that comprises an electrochemiluminescent label and is hybridized to a second nucleic acid molecule, incubating the combined sample to unhybridize the nucleic acid molecules, capture the unhybridized nucleic acid molecules and measure the electrochemiluminescence from the captured nucleic aid molecule.
Patent NZ-519177-A (NZ)
Title: Method and apparatus for delivering program to storage module of mobile terminal
Inventor: NATSUNO TAKESHI
IPC: G06F9/445
Filed: 2002-01-30
Abstract: A program distribution system for distribution of a program to a mobile terminal comprises: a management server; an authentication sever in communication with the management server wherein the authentication server comprises a first public key of the management server and the management server comprises the first private key of the management server; the authentication server is configured to transmit the first public key in response to a request; the management server is configured to receive a program that has been encrypted by a second public key and then by the first public key; wherein the management server is configured to decrypt the program with the first private key and distribute the program still encrypted with the second public key to a destination.
Patent NZ-519497-A (NZ)
Title: New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
Inventor: BJORSNE MAGNUS
IPC: C07D405/12
Filed: 2000-12-19
Abstract: There is provided compounds of formula (I), wherein R1, R2, R3 and Ra to Rh have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias, a process for the preparation of compounds of formula (I), and intermediate compounds.
Patent NZ-520903-A (NZ)
Title: Bifunctional chelating agent
Inventor: QUADI ALI
IPC: A61K51/00
Filed: 2001-03-09
Abstract: A ligand of the formula wherein: n is an integer from 1 to 5; X is selected from the group consisting of -NO2, -NH2, -NCS, -NHCOCH2-Z, NHCO-W-COCNHS, -NH-Q, -NHCS-Q, -NHCOCH2-Q and -NHCO(CH2)m-Q where Q is a hapten chosen from the group consisting of steroids, enzymes, proteins, monoclonal antibodies, chimeric antibodies, and fragments of the other species in this group; Y is CO2H or PO3H2; W is -(CH2)m- where m is an integer from 1 to 10; and Z is selected from the group consisting of chloride, bromide and iodine and its use for the preparation of a medicament for use as a therapeutic or diagnostic agent in radioimmunoimaging and/or radioimmunotherapy.
Patent NZ-525703-A (NZ)
Title: Agrochemical formulation aid composition and uses thereof
Inventor: STEWART JAMES F
IPC: A01N25/00
Filed: 2001-10-26
Abstract: There is provided an agrochemical formulation aid composition for preparing bioactive and sprayable agrochemicals, wherein various components for the composition were selected from mineral oil paraffinic distillate and/or aromatic hydrocarbon distillate; 2N-octanol; oleyl-cetyl alcohol; polyoxyethylene (2) oleylether ; polyoxyethylene (8) nonylphenolethin and/or ethoxylated tallow amine blend; lauryl sulphate; fatty alcohol alkoxylate; terpenes, diammonium phosphate; tetrasodium ethylene diamine tetracetate; cab-o-sil; fatty acid methyl ester; (C18) free fatty acid blend; N-butanol; and methyl alcohol. Also provided are methods of preparing the formulation aid composition on site by mixing various components and methods of preparing sprayable and bioactive agrochemical systems using the formulation aid and non-formulated or formulated agrochemicals. Also provided are uses of the formulation aid in preparing sprayable and bioactive agrochemical systems for controlling pests.
Patent NZ-532867-A (NZ)
Title: A removable lens frame mounted to an eyewear platform
Inventor: ZELMAN GARY M
IPC: G02C1/06
Filed: 2002-11-08
Abstract: Eyeglasses having a lens frame removably attached to an eyewear platform using different attachment devices such as magnets, clips, or other attachment devices that provide effective resistance from said lens frame from becoming involuntarily detached from said eyewear platform. This eyewear allows the user to quickly and easily change lenses or sunglasses.
Patent NZ-533570-A (NZ)
Title: Pipe connector with collar-and-fingers component having finger ends bent inwardly
Inventor: WHITE MICHAEL
IPC: F16L37/092
Filed: 2004-02-12
Abstract: The pipe connector has a hollow body 1 so that a pipe can be inserted into it. A collar-and-fingers component has ring 4 and fingers 5 which are bent inwardly at their free ends. (62) Divided out of 531121
Patent NZ-540299-A (NZ)
Title: Method of increasing the fish catch in the ocean
Inventor: MARKELS MICHAEL
IPC: A01K61/00
Filed: 2003-11-07
Abstract: Disclosed is a method of increasing the fish catch in the ocean comprising the following steps: (1) testing an area of the surface of the ocean to confirm that each macronutrient is present at a first predetermined level that allows for the production of phytoplankton; (2) testing the area of the surface of the ocean to confirm that a first micronutrient is present at a second predetermined level which limits the production of phytoplankton; (3) testing the area of the surface of the ocean to confirm that the rate of diffusion is at a third predetermined level which allows for the production of a patch of phytoplankton; (4) applying a first fertilizer comprising said first micronutrient to create the patch of phytoplankton in the area of the surface of the ocean; and (5) harvesting the fish underneath and in the area of the patch. Also disclosed is a method of creating a fish attractive device comprising the step of applying a first fertilizer to create a first patch of phytoplankton in an area of the surface of the ocean, wherein said first fertilizer comprises a first micronutrient, and wherein said first patch has a size of more than about 0.5 square miles.
Patent NZ-546058-A (NZ)
Title: Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors
Inventor: STYLES MICHELLE LEANNE
IPC: C07D241/20
Filed: 2005-01-12
Abstract: Disclosed is a compound of formula I, or a pharmaceutically acceptable prodrug, salt, hydrate, solvate, crystal form, or diastereoisomer thereof, wherein up to one of X1 to X4 may be nitrogen, and the others are substituted carbon, A is a substituted pyridine, pyrazine, pyrimidine, or 1,3,5-triazine, Q is a bond, C1-4alkyl, O, S, SO, SO2, CO, or CS, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for inhibiting JAK-3, and for treating diseases such as atopy, allergic asthma, atopic dermatitis, allergic rhinitis, cell mediated hypersensitivity, rheumatic diseases, transplant rejection, graft versus host disease, viral diseases, proliferative diseases and cancer.
Patent NZ-548197-A (NZ)
Title: Thiazole derivatives and use thereof
Inventor: QUATTROPANI ANNA
IPC: C07D277/46
Filed: 2005-01-11
Abstract: Disclosed is a thiazole derivative of formula (I), wherein R1 is -NR5R6, X is S or O, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries, and for inhibiting PI3 kinase activity.
Patent NZ-552945-A (NZ)
Title: Imazalil compositions comprising alkoxylated amines
Inventor: BYLEMANS DANY LEOPOLD JOZEFIEN
IPC: A01N33/08
Filed: 2005-08-22
Abstract: Disclosed is a fungicidal composition comprising imazalil (also known as 1-[2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl)]-1H-imidazole) and an alkoxylated amine of formula (I), wherein R1 is a C8-20alkyl, R2 is (a-1) or (a-2), n is between 1 and 4, a, b, and c are each between 1 and 20, and X is H, methyl, ethyl, or phenyl, provided that the compound wherein R1 is C16-18alkyl, R2 is (a-1), and a and b are 1 is excluded. Also disclosed is a method of protecting plants, fruit, or seed against fungal infections or diseases comprising applying the composition to the plant, fruit, or seed.
Patent NZ-554646-A (NZ)
Title: Traction drive for elevator
Inventor: OGAVA MARIO YOSHITARO
Filed: 2007-04-20
Abstract: A traction drive for an elevator comprises a sheave (5) for actuating a transmission means of the elevator and a synchronous motor, said synchronous motor comprising a stator (1) with at least one winding for generating a magnetic field rotating around a motor axis and a rotor (3) comprising at least one permanent magnet (7), the rotor being coupled to the sheave for transmitting a torque. The permanent magnet is longer in the motor axis direction than the stator core. The rotor is composed from a plurality of separate permanent magnets (7) and separate magnetic sectors (6) provided alternating in a circumferential direction perpendicular to the motor axis to concentrate the magnetic flux in axial and/or radial direction.
Patent NZ-556087-A (NZ)
Title: An automated window system with an overcentre drive mechanism
Inventor: ALEXANDER EDWIN JOHN
IPC: E06B7/096
Filed: 2005-12-01
Abstract: Disclosed is a drive mechanism for a louvre window system. The drive mechanism includes an operating bar adapted to open and close the louvres by its movement, a drive wheel means and at least one link member associated with the wheel means and the operating bar. The link member is attached such that linear movement of the operating bar decreases for a unit radial movement of the wheel means during a period when increase load is experienced in the louvre opening or closing sequence.